Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma
Clinical trial NCT02393820 · COMPLETED
Trial details
- NCT number
- NCT02393820
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-26
- Primary completion
- 2015-12-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.